Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q1 2022 · 10-Q
Revenue$269.18M$269.18M+17.3% vs Q1 2021 Net Income$57.76M$57.76M+32.1% vs Q1 2021 EPS Diluted$1.14$1.14+32.6% vs Q1 2021 Gross Profit$159,012,000+18.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flow$69,305,000−7.8% Free Cash Flowderived$67,805,000−6.6% Margins · derivedGross margin59.1%+0.7 pt vs Q1 2021
Operating margin33.9%−1.0 pt vs Q1 2021
Net margin21.5%+2.4 pt vs Q1 2021
ended Jun 30, 2021 · filed Aug 5, 2021 · 36 d after period end